Zomedica
Zomedica, listed on the NYSE American Exchange as 'ZOM', specializes in point-of-care diagnostics and therapeutic products for animals, featuring innovative technologies like TRUFORMA and VetGuardian.
Services
Zomedica provides a comprehensive suite of point-of-care diagnostics and therapeutic products specifically designed for equine and companion animals. The company’s offerings include advanced diagnostic tools and non-invasive therapeutic systems. Zomedica aims to streamline the diagnostic process for veterinarians, from sample collection to result analysis, enabling faster and more efficient decision-making in clinical settings.
Products
Zomedica offers several key products aimed at improving veterinary care. The TRUFORMA platform allows in-clinic diagnostic testing, enabling veterinarians to make quicker diagnostic decisions. Zomedica also provides the PulseVet system, a non-invasive shock wave therapy device. Additionally, the company offers Assisi's targeted pulsed electromagnetic field (tPEMF) therapy, which has been used to treat over 50,000 pets. Another innovative product is VetGuardian, a zero-touch remote monitor for vital signs, enhancing monitoring capabilities without physical contact.
Sector
Zomedica operates within the veterinary diagnostics and therapeutics sector, focusing on both equine and companion animal health. The company’s products cater to veterinary clinics and animal health professionals, offering tools designed to improve diagnostic accuracy and therapeutic outcomes. By targeting this niche market, Zomedica addresses specific needs within the larger animal health industry, providing solutions that enhance the quality and efficiency of veterinary care.
Stock Information
Zomedica is publicly traded on the NYSE American Exchange under the stock symbol 'ZOM'. This listing provides investors with the opportunity to invest in a company specializing in veterinary diagnostics and therapeutic products. The trading symbol 'ZOM' represents Zomedica's commitment to improving animal health through innovative point-of-care solutions.
History
Zomedica has developed a range of diagnostic and therapeutic products aimed at enhancing veterinary practice. Over the years, the company has focused on innovation and the development of point-of-care solutions to improve the quality of care provided to animals. Key milestones include the introduction of the TRUFORMA platform, the PulseVet shock wave therapy system, Assisi’s tPEMF therapy, and the VetGuardian remote monitoring system. Each product addresses a specific need within the veterinary field, contributing to Zomedica’s growth and reputation in the animal health industry.